Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

被引：0

作者：

Evelina Miele

Gian Paolo Spinelli

Federica Tomao

Angelo Zullo

Filippo De Marinis

Giulia Pasciuti

Luigi Rossi

Federica Zoratto

Silverio Tomao

机构：

[1] Department of Experimental Medicine University of Rome "Sapienza" viale Regina Elena 324,Operative Unit of Medical Oncology, S. Maria Goretti Hospital

[2] University of Rome "Sapienza" – Latina-via Canova,Gastroenterology and Digestive Endoscopy

[3] "Nuovo Regina Margherita" Hospital,Thoracic Oncology Unit I, Department of Lung Diseases

[4] San Camillo and Forlanini Hospitals,undefined

来源：

Journal of Experimental & Clinical Cancer Research | / 27卷

关键词：

Positron Emission Tomography; Small Cell Lung Cancer; Mediastinal Lymph Node; Mediastinal Lymph Node Metastasis; Positron Emission Tomography Examination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.

引用

共 50 条

[31] Lymph node staging in non-small cell lung cancer: Evaluation by [F-18]FDG positron emission tomography (PET)
Guhlmann, A
Storck, M
Kotzerke, J
Moog, F
SunderPlassmann, L
Reske, SN
THORAX, 1997, 52 (05) : 438 - 441
[32] The utility of flourine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) for restaging of non-small cell lung cancer (NSCLC): Analysis of management change and survival in 63 consecutive patients.
Hicks, RJ
Binns, D
Kalff, V
Ware, RE
MacManus, MP
Ball, DL
Hogg, A
Matthews, J
JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 75P - 75P
[33] The Role Of Positron Emission Tomography - Computed Tomography (PET/CT) In The Prognosis Of Patients With Non Small Cell Lung Cancer (NSCLC)
Tesfaye, A.
Mozayen, M.
Sarangi, M.
Nagpal, S.
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S295 - S295
[34] Mediastinal lymph node staging in patients with non-small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)
Mendez, Miriam
Maximiano, Constanza
Huelves, Miriam
Gaston, Bernard
de Speville, Doger
Ibeas, Patricia
Ruiz-Valdepenas, Andrea
Palka, Magda
Diaz, Gema
Gomez, David
Provencio, Mariano
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[35] Fluoro deoxy glucose positron emission tomography (FDG-PET) and surgery for epilepsy in the temporal lobe
Boling, WW
Palade, A
EPILEPSIA, 2005, 46 : 165 - 165
[36] Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-D-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancer
Igai, Hitoshi
Gotoh, Masashi
Yokomise, Hiroyasu
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 30 (06) : 837 - 839
[37] Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer
Kaira, Kyoichi
Serizawa, Masakuni
Koh, Yasuhiro
Takahashi, Toshiaki
Yamaguchi, Aiko
Hanaoka, Hirofumi
Oriuchi, Noboru
Endo, Masahiro
Ohde, Yasuhisa
Nakajima, Takashi
Yamamoto, Nobuyuki
LUNG CANCER, 2014, 83 (02) : 197 - 204
[38] Positron emission tomography (PET-FDG) predicts survival in patients with non-small cell lung cancer
Dunagan, DP
Chin, R
Case, DL
McCain, TW
Harkness, BA
Oaks, TE
Haponik, EF
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A715 - A715
[39] Clinical applications of F-18 fluoro-2-deoxy-D-glucose (FDG) positron emission tomography-computed tomography (PET/CT)
Zanoni, Lucia
Al-Sugair, Abdulaziz Saleh
Fanti, Stefano
NUCLEAR MEDICINE REVIEW, 2012, 15 : C48 - C51
[40] Positron emission tomography (PET) of non-small cell lung cancer
Haberkorn, U
LUNG CANCER, 2001, 34 : S115 - S121

← 1 2 3 4 5 →